Matteo Cesaroni

Sanofi R&D
Vitry-sur-seine, 94400, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients.

Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients.

Journal: iScience

Published: July 24, 2024

TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC.

TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 21, 2023

CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses.

CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses.

Journal: iScience

Published: December 16, 2022

Cytotoxic T lymphocyte antigen-4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression.

Cytotoxic T lymphocyte antigen-4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression.

Journal: Clinical and experimental immunology

Published: April 08, 2021

Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition.

Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition.

Journal: Lupus

Published: February 25, 2021

Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus.

Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 22, 2020

First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial.

First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial.

Journal: The Lancet. Rheumatology

Published: April 02, 2020

Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.

Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.

Journal: The Journal of experimental medicine

Published: April 26, 2018

Digital Restriction Enzyme Analysis of Methylation (DREAM).

Digital Restriction Enzyme Analysis of Methylation (DREAM).

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 11, 2017

Correction: Human mutations in integrator complex subunits link transcriptome integrity to brain development.

Correction: Human mutations in integrator complex subunits link transcriptome integrity to brain development.

Journal: PLoS genetics

Published: August 02, 2017

Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.

Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 26, 2017

A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.

A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.

Journal: Leukemia

Published: September 20, 2016

Showing 1-12 of 30

Last Updated: 09/26/2026